In 2024, the global market size of VRE and MRSA Antibiotic was estimated to be worth US$ 4384 million and is forecast to reach approximately US$ 5747 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) are specific, antibiotic-resistant bacteria that spread by contact and can cause s...
The global market for Drugs based on Genetic Engineering was valued at US$ 314526 million in the year 2024 and is projected to reach a revised size of US$ 487657 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Drugs based on genetic engineering are pharmaceutical products developed using biotechnology techniques such as recombinant DNA technology, gene editing, or synthetic...
The global market for Recombinant Protein Drug Therapeutics was valued at US$ 177865 million in the year 2024 and is projected to reach a revised size of US$ 312704 million by 2031, growing at a CAGR of 8.5% during the forecast period.
Recombinant protein therapeutics are biologic drugs produced by introducing the gene encoding a specific therapeutic protein into host cells through recombinant DNA...
The global market for Recombinant DNA Drug was valued at US$ 177865 million in the year 2024 and is projected to reach a revised size of US$ 312704 million by 2031, growing at a CAGR of 8.5% during the forecast period.
Recombinant DNA drugs are therapeutic agents produced using recombinant DNA technology, which involves inserting a gene encoding a therapeutic protein into a host cell (such as bact...
The global market for Recombinant Protein Biopharmaceuticals was valued at US$ 177865 million in the year 2024 and is projected to reach a revised size of US$ 312704 million by 2031, growing at a CAGR of 8.5% during the forecast period.
Recombinant protein biopharmaceuticals are therapeutic proteins produced through recombinant DNA technology, in which genes encoding the desired protein are insert...
The global market for Humanized Monoclonal Antibody Drugs was valued at US$ 132574 million in the year 2024 and is projected to reach a revised size of US$ 259527 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Humanized monoclonal antibody drugs are therapeutic antibodies that are predominantly derived from human antibody structures, but with small portions—typically the c...
The global market for Human-mouse Chimeric Antibody Therapeutics was valued at US$ 21452 million in the year 2024 and is projected to reach a revised size of US$ 28363 million by 2031, growing at a CAGR of 4.2% during the forecast period.
Human-mouse chimeric antibody therapeutics are a class of biologic drugs developed by fusing the antigen-binding variable regions of mouse monoclonal antibodies...
The global market for Human-mouse Chimeric Antibody was valued at US$ 21452 million in the year 2024 and is projected to reach a revised size of US$ 28363 million by 2031, growing at a CAGR of 4.2% during the forecast period.
A human-mouse chimeric antibody is a type of monoclonal antibody engineered by combining the variable regions of a mouse antibody (which determines antigen specificity) with...
The global market for Dihydropyridine Vasodilators was valued at US$ 2153 million in the year 2024 and is projected to reach a revised size of US$ 1792 million by 2031, growing at a CAGR of -2.4% during the forecast period.
Dihydropyridine vasodilators are a subclass of calcium channel blockers that primarily act on vascular smooth muscle to induce vasodilation by inhibiting L-type calcium channel...
The global market for 9α-Hydroxyandrost-4-ene-3,17-dione was valued at US$ 16.7 million in the year 2024 and is projected to reach a revised size of US$ 24.9 million by 2031, growing at a CAGR of 6.3% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustme...
Our team would be happy to assist you with your queries.
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals